Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Cardiology Other
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Cardiology Other
    The benefits of statins in people without established cardiovascular disease but with cardiovascular risk factors: meta-analysis of randomised controlled trials - (BMJ)
    FDA Approves Dronedarone for Atrial Fibrillation or Atrial Flutter - (DGNews)
    Genetic Loci associated with C-reactive protein levels and risk of coronary heart disease - (JAMA)
    Novel and conventional biomarkers for prediction of incident cardiovascular events in the community - (JAMA)
    Kidney function and risk of cardiovascular disease and mortality in women: a prospective cohort study - (BMJ)

    News archive

     Recent webcasts/CME - Cardiology Other
    • State of the Science in Managing the Treatment-Experienced Patient With HIV
    • What's New in Managing Treatment-Experienced Patients With HIV?
    • Applying Data to Practice: Case Vignettes
    • Rheumatoid Arthritis: The Heart of the Matter Assessing Cardiovascular Risk in Patients with Rheumatoid Arthritis
      Supraventricular Tachycardia in Children and Adolescents

      Webcasts/CME archive

       Recent cases - Cardiology Other
        Cardiogenic Shock Caused by Disulfiram
        Congenital Atresia of the Left Main Coronary Artery Associated With Patent Ductus Arteriosus and Aortic Regurgitation
        Pleural Effusion and Pulmonary Hypertension in a Patient With Parkinson Disease Treated With Cabergoline
        A Well-Circumscribed Density Along the Right Heart Border
        A Case of Massive Pulmonary Embolism with ST Elevation in Leads V1-4

        Cases archive
          




        my personal edition > cardiology other > news
        divider

          E-Mail this DGDispatch to a colleague

        DGDispatch


        Leptin Levels Associated With Cardiovascular Risk Factors: Presented at EAS

        By Norra MacReady

        PRAGUE, CZECH REPUBLIC -- April 27, 2005 -- Serum leptin levels correlate with some markers of the metabolic syndrome in obese individuals and could serve as a risk factor for cardiovascular disease, researchers reported here at the 75th European Atherosclerosis Society Congress.

        Luis Lima Faleiro, MD, department of cardiology, Institute Nacional de Saude, Lisbon, Portugal, and colleagues measured serum leptin levels in 42 men and 61 women ranging in age from 30 to 66 years and evaluated them in relation to body mass index (BMI), fasting insulin and glucose levels, insulin sensitivity as measured by the homeostasis model assessment (HOMA), and cholesterol levels.

        Study subjects were at high risk of cardiovascular disease due either to family history or to presence of 1 or more risk factors, Dr. Faleiro said during a poster presentation here on April 25th.

        Among men, the highest leptin tertile was more than 15.2 ng/mL; the middle tertile ranged from 8.99 to 15.2 ng/mL; and the lowest tertile was < 8.99 ng/mL. Among women, the highest to lowest tertiles ranged from > 47.1 ng/mL, 24.6-47.1 ng/mL, and < 24.6 ng/mL, respectively.

        The relationship between serum leptin levels and cardiovascular risk factors varied somewhat according to sex. In women, leptin measurements correlated strongly with BMI, fasting insulin, and HOMA. Weaker but still significant correlations were also seen with serum triglycerides and uric acid levels.

        Men displayed similar correlations between serum leptin levels and BMI, fasting insulin, and HOMA, but not with triglycerides or uric acid. The researchers found no correlations with total, high-density lipoprotein cholesterol or low-density lipoprotein cholesterol levels in either sex.

        Leptin levels also showed a correlation with the number of metabolic risk factors present. These findings varied somewhat according to sex, but in general at least 70% of the people in the lowest quartile of leptin levels (< 5.28 ng/mL for men, < 18.6 ng/mL for women) had no metabolic risk factors. None of the women in this quartile had more than 1 risk factor, while 10% of the men had 2 risk factors.

        The prevalence of multiple risk factors increased with increasing leptin quartile for both sexes, so that 73% of the men in the fourth quartile (> 18.7 ng/mL) had at least 3 risk factors and the remaining 27% had 2, while 33% of the women in the highest quartile (> 49.8 ng/mL) had 3 or more risk factors, 35% had 2, and 13% had 1. Twenty percent of the women in the fourth quartile had no risk factors.

        These findings support the theory that leptin levels should be monitored along with other markers of cardiovascular risk, the investigators said.


        [Presentation title: Leptin, Obesity, and Other Metabolic Syndrome Risk Factors in a Portuguese Population Sample for Cardiovascular Prevention. Poster W08-P17]



        E-Mail this DGDispatch to a colleague   To print, use this version






        All contents Copyright (c) 1995-2009 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send